8-K
filed February 8, 2024, 6:59 PM ET
ticker ATR
CIK 0000896622
earnings
confidence high
sentiment positive
materiality 0.80
Aptar Q4 adjusted EPS $1.21 (up 27%), FY 2023 revenue $3.49B, guides Q1 2024 EPS $1.10-$1.18
APTARGROUP, INC.
2023-FY EPS reported
$4.25
revenue$3,487,450,000
- Q4 reported sales $838M (+5%), net income $62M (+6%), adjusted EPS $1.21 vs $0.95 (up 27%).
- FY 2023 sales $3.49B (+5%), net income $284M (+19%), adjusted EPS $4.78 vs $3.87 (up 24%).
- Pharma core sales +11% in Q4 driven by proprietary drug delivery systems; Beauty -6%, Closures -4%.
- Q1 2024 adjusted EPS guidance $1.10-$1.18; expects continued Pharma growth and market recovery.
- Dividend $0.41 payable Feb 22; repurchased 81k shares for $10.3M in Q4.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
APTARGROUP, INC. reported the quarter ended December 31, 2023 results: net income $62 million, EPS $0.93.
- Period
- the quarter ended December 31, 2023
- Net income
- $62 million
- EPS
- $0.93
- Result
- reported results
Exact text from the filing
Fourth Quarter 2023 Highlights • Reported sales increased 5% and net income increased 6% to $62 million • Core sales increased 2% and adjusted EBITDA increased 22% from the prior year to $179 million • Reported earnings per share increased about 4% to $0.93 compared to $0.89 in the prior year
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
APTARGROUP, INC. reported the year ended December 31, 2023 results: revenue $3.5 billion, net income $284 million, EPS $4.25.
- Period
- the year ended December 31, 2023
- Revenue
- $3.5 billion
- Net income
- $284 million
- EPS
- $4.25
- Result
- reported results
Exact text from the filing
Annual 2023 Highlights • Achieved annual sales of $3.5 billion, with sales growth driven evenly by favorable product mix, volume growth and pricing • Reported sales grew 5% and core sales increased 3% • Reported earnings per share increased 18% to $4.25 and adjusted earnings per share increased 24% to $4.78 • Reported net income increased 19% to $284 million and adjusted EBITDA increased 15% to $708 million
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.